Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | IGF1R | P08069 | 1/20 | 0.30 |
| ▸ | FLT4 | P35916 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21735888 | 0.98 | KDM4E (0.33) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL21736402 | 0.97 | ALDH1A1 (0.35) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL21736565 | 0.94 | ALDH1A1 (0.33) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL21736202 | 0.91 | ALDH1A1 (0.33) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL20669829 | 0.91 | ALDH1A1 (0.34) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL20669800 | 0.89 | ALDH1A1 (0.32) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL21736540 | 0.89 | ALDH1A1 (0.34) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL21736020 | 0.89 | KDM4E (0.32) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL21736013 | 0.89 | SMN1; SMN2 (0.35) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL21474705 | 0.88 | ALOX5 (0.37) | KDM4EMEN1ALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| EP-3553049-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2022-01-19 | — | — | EP | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | KDM4E 1417/4885MEN1 598/4885ALDH1A1 14/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | KDM4E 1417/4885MEN1 598/4885ALDH1A1 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.